Dr. Mya C. Schiess, MD

Dr. Schiess practices at Ut Physicians Neurosciences in Houston, Texas.

Dr. Schiess' NPI, 1568407252, was assigned on June 18, 2006. Dr. Schiess graduated from The University of New Mexico School of Medicine in 1980. Dr. Schiess holds Texas license G7427.

Dr. Schiess' primary practice is Ut Physicians Neurosciences, at 6410 Fannin St Ste 1014 Suite 1014, Houston, TX 77030. The practice phone is (832) 325-7080.

Dr. Schiess' primary practice is Ut Physicians Neurosciences in Houston, Texas. Dr. Schiess is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Schiess to 3 more hospitals, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schiess practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Schiess' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Schiess is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Schiess' licenses on file in 2 states: Texas and Louisiana.

Dmand AI lists epilepsy, essential tremor, hypersomnia, mobility impairment, muscle pain, fibromyalgia, and limb pain, non-alzheimer's dementia (chronic), parkinson's disease and restless legs syndrome among the conditions Dr. Schiess treats.

CMS data shows 748 Medicare services from Dr. Schiess across 5 procedure codes in 2024, for 146 Medicare patients. Medicare paid $54,756 for them. Every service was in an office.

CMS counts 146 Medicare patients who saw Dr. Schiess in 2024. The largest group is 65 to 74, with 71 patients. 71% of them have high cholesterol, and 71% have parkinson's disease. 8% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schiess' median patient age at 72, with 41% women.

In 2024, Dr. Schiess wrote 2,654 Medicare Part D claims for 247 patients. 79% of them were for generic drugs. CMS names the drug for 2,349 of them, across 50 drugs with 11 or more claims each, at $1,145,016 in total drug cost. In 2023, CMS named 1,766 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Schiess for performance year 2024, reported as part of a group. Dr. Schiess accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schiess as offering telehealth.

Dmand AI links 54 papers to Dr. Schiess, published from 2005 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Parkinson Disease, Deep Brain Stimulation and Cells, Cultured. Dr. Schiess has published most often in Arch Neurol. Dr. Schiess' most frequent co-authors are Raja Mehanna, MD, Irene Jennifer Oh, MD and Allison M. Boyle, MD.

Dmand AI links Dr. Schiess to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Parkinson Disease, Parkinsonian Disorders and REM Sleep Behavior Disorder. The University of Texas Health Science Center, Houston sponsors the most, 3.

CMS Open Payments shows 460 general payments to Dr. Schiess from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Medtronic USA, Inc. paid the most, $28,885. It also lists 20 research payments totaling $132,716 from 2019 to 2025.

Dmand AI lists 2 awards for Dr. Schiess, most recently CMS Stage 1 2012 in 2012.

Dr. Schiess graduated from The University of New Mexico School of Medicine in 1980. Dr. Schiess is a member of MDS.

Dr. Schiess is in network with 24 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.